Association Between Lipid Profile and Risk of Incident Systemic Sclerosis: A Nationwide Population-Based Study

被引:1
作者
Kwon, Oh Chan [1 ]
Han, Kyungdo [2 ,3 ]
Park, Min-Chan [1 ,4 ]
机构
[1] Yonsei Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea
[2] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea
[3] Soongsil Univ, Dept Stat & Actuarial Sci, 369 Sangdoro, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Gangnam Severance Hosp, 211 Eonjuro, Seoul 06273, South Korea
来源
CLINICAL EPIDEMIOLOGY | 2023年 / 15卷
关键词
systemic sclerosis; risk factor; total cholesterol; high-density lipoprotein cholesterol; low-density lipoprotein cholesterol; HIGH-DENSITY-LIPOPROTEINS; DISEASE; EPIDEMIOLOGY; INFLAMMATION; CHOLESTEROL; DEATH; SEX;
D O I
10.2147/CLEP.S427881
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background and Aims: Lipid metabolism is altered in systemic sclerosis (SSc), mediating activation of immune cells and fibroblasts. However, it is unclear whether altered lipid profile is associated with a risk of developing SSc. We aimed to assess the association between lipid profile and risk of incident SSc. Methods: From a Korean nationwide database, individuals without SSc who underwent national health check-ups in 2009 were selected and followed-up through 2019. Serum levels of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low -density lipoprotein cholesterol (LDL-C), and triglyceride were measured on the health check-up date in 2009. Individuals who developed SSc during follow-up were identified. Multivariable Cox models were performed to estimate the risk of incident SSc according to TC, HDL-C, LDL-C, and triglyceride levels, respectively. Results: Of the 9,894,996 individuals selected, 1355 individuals developed SSc during a mean follow-up of 9.2 years (incidence rate=1.49 per 100,000 person-years). Levels of TC (adjusted hazard ratio [aHR] 0.959, 95% confidence interval [CI] 0.945-0.974), HDL-C (aHR 0.968, 95% CI 0.950-0.987), LDL-C (aHR 0.968, 95% CI 0.952-0.983) were inversely associated with the risk of incident SSc, whereas no significant association was observed between levels of triglyceride (aHR 1.004, 95% CI 0.998-1.011) and risk of incident SSc. Conclusion: Serum levels of TC, HDL-C, and LDL-C were inversely associated with the risk of incident SSc. Our findings provide new insights that altered lipid profile could be considered a non-causal biomarker associated with incident SSc, which could help early diagnosis. The underlying mechanism for this association needs further studies. Plain Language Summary: Lipid metabolism is altered in patients with systemic sclerosis (SSc), mediating activation of immune cells and fibroblasts. In this large population-based cohort study, we found that levels of TC, HDL-C, and LDL-C were inversely associated with the risk of incident SSc. Our findings suggest that levels of TC, HDL-C, and LDL-C could be considered in detecting individuals at high risk of incident SSc.
引用
收藏
页码:1095 / 1107
页数:13
相关论文
共 42 条
[1]   Risk factors for the development of systemic sclerosis: a systematic review of the literature [J].
Abbot, Samuel ;
Bossingham, David ;
Proudman, Susanna ;
de Costa, Caroline ;
Ho-Huynh, Albert .
RHEUMATOLOGY ADVANCES IN PRACTICE, 2018, 2 (02) :1-12
[2]   Postsurgical reduction of serum lipoproteins: Interleukin-6 and the acute-phase response [J].
Akgun, S ;
Ertel, NH ;
Mosenthal, A ;
Oser, W .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1998, 131 (01) :103-108
[3]   Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease [J].
Bergamasco, Aurore ;
Hartmann, Nadine ;
Wallace, Laura ;
Verpillat, Patrice .
CLINICAL EPIDEMIOLOGY, 2019, 11 :257-273
[4]   Lipoprotein profile in limited systemic sclerosis [J].
Borba, EF ;
Borges, CTL ;
Bonfá, E .
RHEUMATOLOGY INTERNATIONAL, 2005, 25 (05) :379-383
[5]   INCREASED SUSCEPTIBILITY TO OXIDATION OF LOW-DENSITY LIPOPROTEINS ISOLATED FROM PATIENTS WITH SYSTEMIC-SCLEROSIS [J].
BRUCKDORFER, KR ;
HILLARY, JB ;
BUNCE, T ;
VANCHEESWARAN, R ;
BLACK, CM .
ARTHRITIS AND RHEUMATISM, 1995, 38 (08) :1060-1067
[6]   Lipid Metabolism Profiles in Rheumatic Diseases [J].
Chen, Weilin ;
Wang, Qi ;
Zhou, Bin ;
Zhang, Lihua ;
Zhu, Honglin .
FRONTIERS IN PHARMACOLOGY, 2021, 12
[7]  
Davis CE, 1996, AM J EPIDEMIOL, V143, P1100
[8]  
Delisle VC, 2014, CLIN EXP RHEUMATOL, V32, pS10
[9]   Systemic sclerosis [J].
Denton, Christopher P. ;
Khanna, Dinesh .
LANCET, 2017, 390 (10103) :1685-1699
[10]   Type 2 diabetes as an inflammatory disease [J].
Donath, Marc Y. ;
Shoelson, Steven E. .
NATURE REVIEWS IMMUNOLOGY, 2011, 11 (02) :98-107